Mind over hormones: Sex differences in associations of well-being with IGF-I, IGFBP-3 and physical activity in the KORA-Age study

Experimental Gerontology

Volumn 59, Issue , 2014, Pages 58-64

  Emeny, R T ^a   Bidlingmaier, M ^b   Lacruz, M E ^a,c   Linkohr, B ^a   Peters, A ^a   Reincke, M ^b   Ladwig, K H ^a,d  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Aging; IGF 1; IGFBP 3; Physical activity; Well being

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; IGFBP3 PROTEIN, HUMAN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPRESSION; DISEASE ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL WELL BEING; SEX DIFFERENCE; SLEEP; SMOKING; VERY ELDERLY; AGING; BLOOD; FEMALE; GERIATRIC ASSESSMENT; MALE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; QUALITY OF LIFE; SEXUAL DEVELOPMENT;

AGED; AGED, 80 AND OVER; AGING; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; GERIATRIC ASSESSMENT; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MOTOR ACTIVITY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; QUALITY OF LIFE; SEX CHARACTERISTICS;

EID: 84912140293     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.08.001     Document Type: Article

References (54)

1. Arvat E., Giordano R., Gianotti L., Broglio F., Camanni F., Ghigo E. Neuroendocrinology of the human growth hormone-insulin-like growth factor I axis during ageing. Growth Horm. IGF Res. 1999, 9(Suppl. A):111-115.
2. Arwert L.I., Deijen J.B., Drent M.L. The relation between insulin-like growth factor I levels and cognition in healthy elderly: a meta-analysis. Growth Horm. IGF Res. 2005, 15:416-422.
3. Auer M., Sievers C., Schneider H.J., Stalla G.K. The GH/IGF-1-Axis in psychopathological functions. Open Endocrinol. J. 2012, 6:62-67.
4. Baxter R.C. Insulin-like growth factor binding protein-3 (IGFBP-3): novel ligands mediate unexpected functions. J. Cell. Commun. Signal. 2013, 7:179-189.
5. Bech P. Measuring the dimensions of psychological general well-being by the WHO-5. QoL Newsl. 2004, 32:15-16.
6. Bech P., Olsen L.R., Kjoller M., Rasmussen N.K. Measuring well-being rather than the absence of distress symptoms: a comparison of the SF-36 Mental Health subscale and the WHO-Five Well-Being Scale. Int. J. Methods Psychiatr. Res. 2003, 12:85-91.
7. Bermon Ferrari, Bernard Altare, Dolisi Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiol. Scand. 1999, 165:51-56.
8. Bidlingmaier M., Friedrich N., Emeny R.T., Spranger J., Wolthers O.D., Roswall J., Koerner A., Obermayer-Pietsch B., Hübener C., Dahlgren J., Frystyk J., Pfeiffer A.F.H., Doering A., Bielohuby M., Wallaschofski H., Arafat A.M. Reference intervals for insulin-like growth-factor-I (IGF-I) from birth to senescence: results from a multicenter study using a new automated chemiluminescence IGF-I immunoassay conforming to recent international recommendations. J. Clin. Endocrinol. Metab. 2014, 1712-1721.
9. Birket-Smith M., Hansen B.H., Hanash J.A., Hansen J.F., Rasmussen A. Mental disorders and general well-being in cardiology outpatients-6-year survival. J. Psychosom. Res. 2009, 67:5-10.
10. Boehm J.K., Kubzansky L.D. The heart's content: the association between positive psychological well-being and cardiovascular health. Psychol. Bull. 2012, 138:655-691.
11. Brandt J., Spencer M., Folstein M. The telephone interview for cognitive status. Cogn. Behav. Neurol. 1988, 1:111-118.
12. Burgers A.M., Biermasz N.R., Schoones J.W., Pereira A.M., Renehan A.G., Zwahlen M., Egger M., Dekkers O.M. Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality. J. Clin. Endocrinol. Metab. 2011, 96:2912-2920.
13. Cassilhas R.C., Antunes H.K., Tufik S., de Mello M.T. Mood, anxiety, and serum IGF-1 in elderly men given 24weeks of high resistance exercise. Percept. Mot. Skills 2010, 110:265-276.
14. Ceda G.P., Dall'Aglio E., Morganti S., Denti L., Maggio M., Lauretani F., Andrea A., Ceresini G., Cattabiani C., Valenti G. Update on new therapeutic options for the somatopause. Acta Biomed. 2010, 81(Suppl. 1):67-72.
15. Chida Y., Steptoe A. Positive psychological well-being and mortality: a quantitative review of prospective observational studies. Psychosom. Med. 2008, 70:741-756.
16. de Gonzalo-Calvo D., Fernandez-Garcia B., de Luxan-Delgado B., Rodriguez-Gonzalez S., Garcia-Macia M., Suarez F.M., Solano J.J., Rodriguez-Colunga M.J., Coto-Montes A. Long-term training induces a healthy inflammatory and endocrine emergent biomarker profile in elderly men. Age 2012, 34:761-771.
17. Deak F., Sonntag W.E. Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1. J. Gerontol. A: Biol. Med. Sci. 2012, 67:611-625.
18. Deijen J.B., Arwert L.I., Witlox J., Drent M.L. Differential effect sizes of growth hormone replacement on quality of life, well-being and health status in growth hormone deficient patients: a meta-analysis 7. Health Qual. Life Outcomes 2005, 3:63.
19. Deuschle M., Blum W.F., Strasburger C.J., Schweiger U., Weber B., Korner A., Standhardt H., Gotthardt U., Schmider J., Pflaum C.D., Heuser I. Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients. Psychoneuroendocrinology 1997, 22:493-503.
20. Di Somma C., Brunelli V., Savanelli M.C., Scarano E., Savastano S., Lombardi G., Colao A. Somatopause: state of the art. Minerva Endocrinol. 2011, 36:243-255.
21. Duron E., Funalot B., Brunel N., Coste J., Quinquis L., Viollet C., Belmin J., Jouanny P., Pasquier F., Treluyer J.-M., Epelbaum J., le Bouc Y., Hanon O. Insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Alzheimer's disease. J. Clin. Endocrinol. Metab. 2012, 97:4673-4681.
22. Fanciulli G., Delitala A., Delitala G. Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone. Hum. Reprod. Update 2009, 15:341-358.
23. Filipsson Nyström H., Barbosa E.J.L., Nilsson A.G., Norrman L.-L., Ragnarsson O., Johannsson G. Discontinuing long-term GH replacement therapy-a randomized, placebo-controlled crossover trial in adult GH deficiency. J. Clin. Endocrinol. Metab. 2012, 97:3185-3195.
24. Friedrich N., Wolthers O.D., Arafat A.M., Emeny R.T., Spranger J., Roswall J., Kratzsch J., Grabe H.J., Hübener C., Pfeiffer A.F.H., Doering A., Bielohuby M., Dahlgren J., Frystyk J., Wallaschofski H., Bidlingmaier M. Age and sex specific reference intervals across life-span for insulin-like growth factor binding protein 3 (IGFBP-3) and the IGF-I/IGFBP-3 ratio measured by new automated chemiluminescence assays. J. Clin. Endocrinol. Metab. 2014, 1675-1686.
25. Giltay E.J., Geleijnse J.M., Zitman F.G., Hoekstra T., Schouten E.G. Dispositional optimism and all-cause and cardiovascular mortality in a prospective cohort of elderly Dutch men and women. Arch. Gen. Psychiatry 2004, 61:1126-1135.
26. Greenland S., Pearl J., Robins J.M. Causal diagrams for epidemiologic research. Epidemiology 1999, 10:37-48.
27. Helmich I., Latini A., Sigwalt A., Carta M.G., Machado S., Velasques B., Ribeiro P., Budde H. Neurobiological alterations induced by exercise and their impact on depressive disorders [corrected]. Clin. Pract. Epidemiol. Ment. Health 2010, 6:115-125.
28. Holle R., Happich M., Lowel H., Wichmann H.E. KORA-a research platform for population based health research. Gesundheitswesen 2005, 67(Suppl. 1):S19-S25.
29. Howell R.T. Review: positive psychological well-being reduces the risk of mortality in both ill and healthy populations. Evid. Based Ment. Health 2009, 12:41.
30. Ikonen M., Liu B., Hashimoto Y., Ma L., Lee K.W., Niikura T., Nishimoto I., Cohen P. Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:13042-13047.
31. Janssen J.A., Stolk R.P., Pols H.A., Grobbee D.E., Lamberts S.W. Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 levels in healthy elderly individuals. Relation to self-reported quality of health and disability. Gerontology 1998, 44:277-280.
32. Koopmans K.A., Geleijnse J.M., Zitman F.G., Giltay E.J. Effects of happiness on all-cause mortality during 15years of follow-up: the Arnhem Elderly study. J. Happiness Stud. 2010, 11:113-124.
33. Lacruz M.E., Emeny R.T., Bickel H., Cramer B., Kurz A., Bidlingmaier M., Huber D., Klug G., Peters A., Ladwig K.H. Mental health in the aged: prevalence, covariates and related neuroendocrine, cardiovascular and inflammatory factors of successful aging. BMC Med. Res. Methodol. 2010, 10:36.
34. Lacruz M.E., Emeny R.T., Baumert J., Ladwig K.H. Prospective association between self-reported life satisfaction and mortality: results from the MONICA/KORA Augsburg S3 survey cohort study. BMC Public Health 2011, 11:579.
35. Lacruz M., Emeny R., Bickel H., Linkohr B., Ladwig K. Feasibility, internal consistency and covariates of TICS-m (telephone interview for cognitive status-modified) in a population-based sample: findings from the KORA-Age study. Int. J. Geriatr. Psychiatry 2013, 28:971-978.
36. Landi F., Capoluongo E., Russo A., Onder G., Cesari M., Lulli P., Minucci A., Pahor M., Zuppi C., Bernabei R. Free insulin-like growth factor-I and cognitive function in older persons living in community. Growth Horm. IGF Res. 2007, 17:58-66.
37. Lowel H., Doring A., Schneider A., Heier M., Thorand B., Meisinger C. The MONICA Augsburg surveys-basis for prospective cohort studies. Gesundheitswesen 2005, 67(Suppl. 1):S13-S18.
38. Meisinger C., Heier M., Loewel H. Sleep disturbance as a predictor of type 2 diabetes mellitus in men and women from the general population. Diabetologia 2005, 48:235-241.
39. Moock J., Albrecht C., Friedrich N., Volzke H., Nauck M., Koltowska-Haggstrom M., Kohlmann T., Wallaschofski H. Health-related quality of life and IGF-1 in GH-deficient adult patients on GH replacement therapy: analysis of the German KIMS data and the Study of Health in Pomerania. Eur. J. Endocrinol. 2009, 160:17-24.
40. O'Connor J.C., McCusker R.H., Strle K., Johnson R.W., Dantzer R., Kelley K.W. Regulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinology. Cell. Immunol. 2008, 252:91-110.
41. Parekh N., Roberts C.B., Vadiveloo M., Puvananayagam T., Albu J.B., Lu-Yao G.L. Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey (1988-1994). Ann. Epidemiol. 2010, 20:182-193.
42. Paslakis G., Blum W.F., Deuschle M. Intranasal insulin-like growth factor I (IGF-I) as a plausible future treatment of depression. Med. Hypotheses 2012, 79:222-225.
43. Peters A., Doring A., Ladwig K.H., Meisinger C., Linkohr B., Autenrieth C., Baumeister S.E., Behr J., Bergner A., Bickel H., Bidlingmaier M., Dias A., Emeny R.T., Fischer B., Grill E., Gorzelniak L., Hansch H., Heidbreder S., Heier M., Horsch A., Huber D., Huber R.M., Jorres R.A., Kaab S., Karrasch S., Kirchberger I., Klug G., Kranz B., Kuch B., Lacruz M.E., Lang O., Mielck A., Nowak D., Perz S., Schneider A., Schulz H., Muller M., Seidl H., Strobl R., Thorand B., Wende R., Weidenhammer W., Zimmermann A.K., Wichmann H.E., Holle R. Multimorbidity and successful aging: the population-based KORA-Age study. Z. Gerontol. Geriatr. 2011, 44(Suppl. 2):41-54.
44. Ryff C.D., Dienberg Love G., Urry H.L., Muller D., Rosenkranz M.A., Friedman E.M., Davidson R.J., Singer B. Psychological well-being and ill-being: do they have distinct or mirrored biological correlates?. Psychother. Psychosom. 2006, 75:85-95.
45. Schilling C., Blum W.F., Heuser I., Paslakis G., Wudy S.A., Deuschle M. Treatment with antidepressants increases insulin-like growth factor-I in cerebrospinal fluid. J. Clin. Psychopharmacol. 2011, 31:390-392.
46. Seigel K., Broman J.E., Hetta J. Behavioral activation or inhibition during emotional stress-implications for exercise habits and emotional problems among young females. Nord. J. Psychiatry 2002, 56:441-446.
47. Shah N., Rice T., Tracy D., Rohan T., Buzkova P., Newman A., Kaplan R.C. Sleep and insulin-like growth factors in the cardiovascular health study. J. Clin. Sleep Med. 2013, 9:1245-1251.
48. Singh N.A., Clements K.M., Singh M.A.F. The efficacy of exercise as a long-term antidepressant in elderly subjects: a randomized, controlled trial. J. Gerontol. A: Biol. Med. Sci. 2001, 56:M497-M504.
49. So W.Y., Song M., Park Y.H., Cho B.L., Lim J.Y., Kim S.H., Song W. Body composition, fitness level, anabolic hormones, and inflammatory cytokines in the elderly: a randomized controlled trial. Aging Clin. Exp. Res. 2013, 25:167-174.
50. Sodergren M., Wang W.C., Salmon J., Ball K., Crawford D., McNaughton S.A. Predicting healthy lifestyle patterns among retirement age older adults in the WELL study: a latent class analysis of sex differences. Maturitas 2014, 77:41-46.
51. Sonntag W.E., Csiszar A., deCabo R., Ferrucci L., Ungvari Z. Diverse roles of growth hormone and insulin-like growth factor-1 in mammalian aging: progress and controversies. J. Gerontol. A: Biol. Med. Sci. 2012, 67:587-598.
52. Textor J., Hardt J., Knuppel S. DAGitty: a graphical tool for analyzing causal diagrams. Epidemiology 2011, 22:745.
53. von Elm E., Altman D.G., Egger M., Pocock S.J., Gotzsche P.C., Vandenbroucke J.P., Initiative S. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 2008, 61:344-349.
54. Vottero A., Guzzetti C., Loche S. New aspects of the physiology of the GH-IGF-1 axis. Endocr. Dev. 2013, 24:96-105.